Skip to main content

Advertisement

SpringerLink
Log in

Predicting Upper Urinary Tract Risk in the Neurogenic Bladder Patient

  • Voiding Dysfunction Evaluation (B Brucker and B Peyronnet, Section Editors)
  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

In this review, we explore if risk factors for developing renal deterioration can be identified in a timely fashion, thereby preventing or delaying the progression of renal injury in the neurogenic bladder patient.

Recent Findings

Historically detrusor leak point pressure (DLPP) > 40 cm H2O has been used to identify risk of upper urinary tract dysfunction (UUTD). Recent studies suggest that DLPP should not be the only decision-making parameter to predict the risk of UUTD and that patients with DLPP > 20 cm H2O should be followed closely for upper tract assessment. Furthermore, a variety of urinary biomarkers can be used markers of UUTD to guide management of neurogenic patients.

Summary

Urodynamic studies represent a valuable tool in the evaluation and monitoring of urinary tract function. Multiple sources have emphasized the early identification and regular follow-up of these patients to not only have a baseline urinary tract function but also to monitor renal function and evaluate for upper tract damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Dorsher P, McIntosh P. Neurogenic Bladder. Ther Adv Urol. 2012;2012:816274. https://doi.org/10.1155/2012/816274.

    Article  Google Scholar 

  2. Powell C. Not all neurogenic bladders are the same: a proposal for a new neurogenic bladder classification system. Transl Androl Urol. 2016;5:12–21. https://doi.org/10.3978/j.issn.2223-4683.2016.01.02.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Tudor K, Sakakibara R, Panicker J. Neurogenic lower urinary tract dysfunction: evaluation and management. J Neurol. 2016;263:2555–64. https://doi.org/10.1007/s00415-016-8212-2.

    Article  PubMed  Google Scholar 

  4. Koprowski C, Friel B, Kim C, Radadia KD, Tunuguntla H, et al. Urodynamic evaluation of adult neurogenic lower urinary tract dysfunction: a review. Am J Urol Res. 2017;2:029–37.

    Article  Google Scholar 

  5. Gormley E. Urologic complications of the neurogenic bladder. Urol Clin North Am. 2010;37:601–7. https://doi.org/10.1016/j.ucl.2010.07.002.

    Article  PubMed  Google Scholar 

  6. Pannek J, Blok B, Castro-Diaz D, Del Popolo G, Kramer G, Radziszewski P, et al. Guidelines on neurogenic lower urinary tract dysfunction. Eur Urol, 2013.

  7. Stohrer M, Blok B, Castro-Diaz D, Chartier-Kastler E, et al. EAU guidelines on neurogenic lower urinary tract dysfunction. Eur Urol. 2009;56:81–8.

    Article  Google Scholar 

  8. Lai S, Pastore S, Piloni L, Mangiulli M, Esposito Y, Pierella F, et al. Chronic kidney disease and urological disorders: systematic use of uroflowmetry in nephropathic patients. Clin Kidney J. 2018;12:414–9. https://doi.org/10.1093/ckj/sfy085.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Klatt E. The kidney. In: Robbins S, Contran R, Klatt E, editors. Robbins and Cotran atlas of pathology. 3rd ed. Philidelphia: Elsevier; 2015.

    Google Scholar 

  10. Fox J, Dudley A, Bates C, Cannon G. Cystatin C as a marker of early renal insufficiency in children with congenital neuropathic bladder. J Urol. 2014;191:1602–7. https://doi.org/10.1016/j.juro.2013.09.093.

    Article  CAS  PubMed  Google Scholar 

  11. Yavuz S, Anarat A, Bayazıt A. Assessment of cystatin C and cystatin C-based GFR formulas in reflux nephropathy. J Pediatr Urol. 2014;10:262–7. https://doi.org/10.1016/j.jpurol.2013.08.010.

    Article  PubMed  Google Scholar 

  12. • Musco S, Padilla-Fernández B, Del Popolo G, et al. Value of urodynamic findings in predicting upper urinary tract damage in neuro-urological patients: a systematic review. Neurourol Urodyn. 2018;37:1522–40. https://doi.org/10.1002/nau.23501. They concluded that spina bifida and SCI pose higher risk of upper tract damage than MS.

  13. • Çetinel B, Önal B, Can G, Talat Z, Erhan B, Gündüz B. Risk factors predicting upper urinary tract deterioration in patients with spinal cord injury: a retrospective study. Neurourol Urodyn. 2016;36:653–8. https://doi.org/10.1002/nau.22984. Delineated risk factors for UUTD in SCI patients.

  14. • Zhang Z, Liao L. Risk factors predicting upper urinary tract deterioration in patients with spinal cord injury: a prospective study. Spinal Cord. 2014;52:468–71. https://doi.org/10.1038/sc.2014.63. Found that lumbosacral injuries are more predictive for UUTD and that catheter-free patients have a lower rate of UUTD compared to indwelling catheter patients.

  15. Cho AJ, Kim SJ, Lee YK, Song YR, Oh J, Kim SG, et al. Effect of postvoiding urine volume on progression of renal function decline in patients with type 2 diabetes. Diabetes Res Clin Pract. 2015;109:164–9. https://doi.org/10.1016/j.diabres.2015.04.014.

    Article  PubMed  Google Scholar 

  16. Kitami K. Vesicourethral dysfunction of diabetic patients. Nippon Hinyokika Gakkai Zasshi. 1991;82:1074–83. https://doi.org/10.5980/jpnjurol1989.82.1074.

    Article  CAS  PubMed  Google Scholar 

  17. Cotter KJ, Levy ME, Goldfarb RA, Liberman D, Katorski J, et al. Urodynamic findings in adults with moderate to severe cerebral palsy. J Urol. 2016;95:216–21. https://doi.org/10.1016/j.urology.2016.05.024.

    Article  Google Scholar 

  18. Gundogdu G, Komur M, Avlan D, Sari FB, Delibas A, et al. Relationship of bladder dysfunction with upper urinary tract deterioration in cerebral palsy. J Pediatr Urol. 2013;9(5):659–64. https://doi.org/10.1016/j.purol.2012.07.020.

    Article  PubMed  Google Scholar 

  19. Zhu H, Zhang D, Zan Y, Yang W. Relationship between detrusor wall thickness and the function of lower urinary tract in patients with spinal cord injury. Int J Clin Exp Med. 2016;9:2269–76. https://doi.org/10.1016/j.pmrj.2014.08.082.

    Article  CAS  Google Scholar 

  20. Ineichen B, Schneider M, Hlavica M, Hagenbuch N, Linnebank M, Kessler T. High EDSS can predict risk for upper urinary tract damage in patients with multiple sclerosis. Mult Scler. 2017;24:529–34. https://doi.org/10.1177/1352458517703801.

    Article  PubMed  Google Scholar 

  21. Rosier PFWM, Schaefer W, Lose G, Goldman HS, et al. International continence society good urodynamic practices and terms 2016: urodynamics, uroflowmetry, cystometry and pressure-flow study. Neurourol Urodyn. 2017;36:1243–60. https://doi.org/10.1002/nau.23124.

    Article  PubMed  Google Scholar 

  22. •• McGuire E, Woodside J, Borden T, Weiss R. Prognostic Value of Urodynamic Testing in Myelodysplastic Patients. J Urol. 1981;126:205–9. https://doi.org/10.1016/s0022-5347(17)54449-3. Defined DLPP < 40 cm H2O as risk factor for upper tract deterioration.

  23. •• Tarcan T, Demirkesen O, Plata M, Castro-Diaz D. ICS teaching module: Detrusor leak point pressures in patients with relevant neurological abnormalities. Neurourol Urodyn. 2015;36:259–62. https://doi.org/10.1002/nau.22947. Proposed that DLPP cutoff of 20 cm H2O shows higher sensitivity in predicting UUTD than 40 cm H2O.

  24. •• Wyndaele J, Gammie A, Bruschini H, De Wachter S, Fry C, Jabr R, et al. Bladder compliance what does it represent: Can we measure it, and is it clinically relevant? Neurol Urodyn. 2011;30:714–22. https://doi.org/10.1002/nau.21129. Defined compliance and proposed risk populations for UUTD.

  25. Wein A. Re: when should video be added to conventional urodynamics in adults and is it justified by the evidence? ICI-RS 2014. J Urol. 2016;196:844–8. https://doi.org/10.1016/j.juro.2016.06.070.

    Article  PubMed  Google Scholar 

  26. Şekerci Ç, İşbilen B, İşman F, Akbal C, Şimşek F, Tarcan T. Urinary NGF, TGF-β1, TIMP-2 and bladder wall thickness predict neurourological findings in children with myelodysplasia. J Urol, 2014:191:199–205. https://doi.org/10.1016/j.juro.2013.08.025.

  27. Forster C, Goldstein S, Pohl H, Jackson E. Association between urodynamic parameters and urine neutrophil gelatinase–associated lipocalin concentrations in children with neuropathic bladders. J Pediatr Urol. 2019;15:155–e1–155.e6. https://doi.org/10.1016/j.jpurol.2018.12.008.

    Article  PubMed  Google Scholar 

  28. Sung B, Oh D, Choi M, Choi H. Chronic kidney disease in neurogenic bladder. Nephrology. 2018;23:231–6. https://doi.org/10.1111/nep.12990.

    Article  CAS  PubMed  Google Scholar 

  29. Amarenco G, Sutory M, Zachoval R, Agarwal M, Del Popolo G, Tretter R, et al. Solifenacin is effective and well tolerated in patients with neurogenic detrusor overactivity: results from the double blind, randomized, active- and placebo-controlled SONIC urodynamic study. Neurourol Urodyn. 2017;36:414–21. https://doi.org/10.1002/nau.22945.

    Article  CAS  PubMed  Google Scholar 

  30. Sugiyama H, Uemura O, Mori T, Okisio N, Unai K, Liu M. Effect of imidafenacin on the urodynamic parameters of patients with indwelling bladder catheters due to spinal cord injury. Spinal Cord. 2017;55:187–91. https://doi.org/10.1038/sc.2016.168.

    Article  CAS  PubMed  Google Scholar 

  31. Ni J, Wang X, Cao N, Si J, Gu B. Is repeat Botulinum Toxin A injection valuable for neurogenic detrusor overactivity-a systematic review and meta-analysis. Neurourol Urodyn. 2018;37:542–53. https://doi.org/10.1002/nau.23354.

    Article  CAS  PubMed  Google Scholar 

  32. Schröder A, Albrecht U, Schnitker J, Reitz A, Stein R. Efficacy, safety, and tolerability of intravesically administered 0.1% oxybutynin hydrochloride solution in adult patients with neurogenic bladder: a randomized, prospective, controlled multi-center trial. Neurourol Urodyn. 2016;35:582–8. https://doi.org/10.1002/nau.22755.

    Article  CAS  PubMed  Google Scholar 

  33. Liao L. Evaluation and management of neurogenic bladder: what is new in China? Int J Mol Sci. 2015;16:18580–600. https://doi.org/10.3390/ijms160818580.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Henry Ford Hospital, 2799 W. Grand Blvd, Detroit, MI, 48202, USA

    Natalija Kovacevic, Samantha Raffee & Humphrey O. Atiemo

  2. Oakland University William Beaumont School of Medicine, 586 Pioneer Dr., Rochester, MI, 48309, USA

    Namita Natalie Lopes

Authors
  1. Natalija Kovacevic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Namita Natalie Lopes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Samantha Raffee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Humphrey O. Atiemo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Humphrey O. Atiemo.

Ethics declarations

Conflict of Interest

Natalija Kovacevic, Namita Lopes, Samantha Raffee, and Humphrey Atiemo declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Voiding Dysfunction Evaluation

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kovacevic, N., Lopes, N.N., Raffee, S. et al. Predicting Upper Urinary Tract Risk in the Neurogenic Bladder Patient. Curr Bladder Dysfunct Rep 15, 66–71 (2020). https://doi.org/10.1007/s11884-020-00578-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-020-00578-0

Keywords

Search

Navigation